A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Clinical trial NCT05979441 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05979441
Sponsor: argenx
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Myositis Active Idiopathic Inflammatory Myopathy Dermatomyositis Polymyositis Immune-Mediated Necrotizing Myopathy Antisynthetase Syndrome

Start date: 2023-09-12
Primary completion: 2028-09-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.